Avitas Wealth Management LLC Invitae Corp Transaction History

Avitas Wealth Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 12, 2021	SELL	$26.09 - $40.4 $446,817 - $691,890	-17,126 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $6,083 - $10,475	-184 Reduced 1.06%	17,126 $654,000
Q4 2020 Feb 26, 2021	BUY	$39.09 - $57.4 $14,111 - $20,721	361 Added 2.13%	17,310 $724,000
Q3 2020 Oct 06, 2020	SELL	$28.43 - $44.67 $148,290 - $232,998	-5,216 Reduced 23.53%	16,949 $735,000
Q2 2020 Jul 30, 2020	SELL	$11.71 - $30.29 $1,721 - $4,452	-147 Reduced 0.66%	22,165 $671,000
Q1 2020 May 13, 2020	SELL	$7.64 - $27.5 $154,687 - $556,792	-20,247 Reduced 47.57%	22,312 $305,000
Q4 2019 Feb 13, 2020	BUY	$15.02 - $20.57 $193,773 - $265,373	12,901 Added 43.5%	42,559 $686,000
Q3 2019 Oct 18, 2019	BUY	$18.85 - $27.5 $204,541 - $298,402	10,851 Added 57.7%	29,658 $572,000
Q2 2019 Jul 23, 2019	SELL	$17.37 - $26.27 $312,955 - $473,306	-18,017 Reduced 48.93%	18,807 $442,000
Q1 2019 May 01, 2019	SELL	$10.65 - $25.75 $24,548 - $59,353	-2,305 Reduced 5.89%	36,824 $862,000
Q4 2018 Feb 08, 2019	BUY	$9.26 - $16.38 $362,334 - $640,933	39,129 New	39,129 $433,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Avitas Wealth Management LLC with notifications on news.